Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Times Interest Earned (2016 - 2026)

Amphastar Pharmaceuticals has reported Times Interest Earned over the past 13 years, most recently at -$11.89 for Q4 2025.

  • For Q4 2025, Times Interest Earned fell 269.23% year-over-year to -$11.89; the TTM value through Dec 2025 reached $1.02, down 84.95%, while the annual FY2025 figure was $1.02, 84.95% down from the prior year.
  • Times Interest Earned for Q4 2025 was -$11.89 at Amphastar Pharmaceuticals, down from $4.03 in the prior quarter.
  • Over five years, Times Interest Earned peaked at $144.36 in Q4 2021 and troughed at -$11.89 in Q4 2025.
  • A 5-year average of $39.35 and a median of $9.38 in 2023 define the central range for Times Interest Earned.
  • Biggest five-year swings in Times Interest Earned: skyrocketed 341.24% in 2021 and later tumbled 269.23% in 2025.
  • Year by year, Times Interest Earned stood at $144.36 in 2021, then plummeted by 50.37% to $71.65 in 2022, then plummeted by 92.03% to $5.71 in 2023, then increased by 23.08% to $7.03 in 2024, then crashed by 269.23% to -$11.89 in 2025.
  • Business Quant data shows Times Interest Earned for AMPH at -$11.89 in Q4 2025, $4.03 in Q3 2025, and $6.72 in Q2 2025.